Hemogenyx Pharmaceuticals PLC (HEMO)

London
1.334
+0.034(+2.62%)
  • Volume:
    3,144,404
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.334 - 1.334

HEMO Overview

Prev. Close
1.3
Day's Range
1.334-1.334
Revenue
-
Open
1.3
52 wk Range
1.05-3.1
EPS
-0.01
Volume
3,144,404
Market Cap
13.13M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,026,473
P/E Ratio
-
Beta
4.25
1-Year Change
-40.71%
Shares Outstanding
979,749,321
Next Earnings Date
-
What is your sentiment on Hemogenyx Pharma?
or
Market is currently closed. Voting is open during market hours.

Hemogenyx Pharmaceuticals PLC Company Profile

Hemogenyx Pharmaceuticals PLC Company Profile

Employees
10

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
  • The end is nigh
    0
    • Htf is silver falcon
      0
      • Mm playing games
        0
        • Now is a good time to buy following the larest announcement with USA approvals
          1
          • I think it's good time to Buy
            0
            • Nowhere apparently other than the bin. Drastically down. No chsnge to candiades tho. LTH this one, its down massively cos of financing and sentiment on the fact. Once sorted and trisls begin, long term could be a great stock, for now its hold
              1
              • Where is thid going other than the bin?
                1
                • It's a dog vlad is just a herbalist his Mrs reads tealeaves
                  1
              • The RNS was a great start. Vlad was right when he said some good news was coming in.
                1
                • Fantastic low price for new investors to get on board !! Get in while you can !! you would be insane not to at this bargain SP !!
                  0
                  • https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
                    0